Bristol-Myers Squibb CompanyStock Price and Value Analysis

Should you buy Bristol-Myers Squibb Company stock? (NYSE:BMY). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company is very stable.
  • This company is making money at a decent rate.
  • This company has a high dividend yield.
  • This company has wild ups and downs.
  • This stock looks overpriced.

BMY Free Cash Flow Trend

Based on historical returns, we believe that Bristol-Myers Squibb Company can grow its free cash at a rate of about 5%. That's positive!

Free Cash Flow trendline for BMY
Free Cash Flow trendline for Bristol-Myers Squibb Company

Inside the BMY Numbers

BMY Price
(Bristol-Myers Squibb Company stock price per share)
$62.42
[?] BMY Fair Price
(based on intrinsic value)
$16.12
[?] BMY Safety Price (based on a variable margin of safety) $12.90
[?] PE Ratio versus Sector 20% higher than other Healthcare stocks
[?] PE Ratio versus Industry 42% higher than other Drug Manufacturers - Major stocks
[?] Cash Yield 1.36%
[?] Free Cash Flow Jitter 40%
[?] Dividend Yield 3%

Is Bristol-Myers Squibb Company Stock on Sale?

We believe that Bristol-Myers Squibb Company may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Bristol-Myers Squibb Company looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy BMY Stock?

Does Bristol-Myers Squibb Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.